Commentary: Right Ventricular Enhancements in HLHS; A Platform for Progress
Volume: 33, Issue: 3, Pages: 802 - 803
Published: Jan 1, 2021
Abstract
Vincenti and colleagues report an extension of findings from the multi-institutional trial to assess the impact of autologous umbilical cord blood-derived mononuclear cells delivered to patients with hypoplastic left heart syndrome (HLHS) at Stage II surgery. 1 Vincenti M. O'Leary P.W. Qureshi M.Y. et al. Clinical impact of autologous cell therapy on hypoplastic left heart syndrome after bidirectional cavopulmonary anastomosis. Semin Thorac...
Paper Details
Title
Commentary: Right Ventricular Enhancements in HLHS; A Platform for Progress
Published Date
Jan 1, 2021
Volume
33
Issue
3
Pages
802 - 803
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History